Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-007-0 | CAS number: 67762-26-9 This substance is identified by SDA Substance Name: C14-C18 and C16-C18 unsaturated alkyl carboxylic acid methyl ester and SDA Reporting Number: 04-010-00.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Remarks:
- read-across on structural analogue
- Adequacy of study:
- key study
- Study period:
- From 1999-04-09 To 1999-08-20
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was performed according to OECD guideline 406 and GLP but is used in read across based on grouping of substances
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The LLNA test has not been performed because a valid Guinea Pig maximisation test is existing.
The existing study was performed according to OECD guideline 406 and GLP. - Species:
- guinea pig
- Strain:
- other: Hartley / Crl: (HA) Br
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River France, 76410 Saint-Aubin-lès-Elbeuf, France.
- Age at study initiation: approximately 3 months old
- Weight at study initiation: 378 +/- 14 g (males), 368 +/- 16 g (females)
- Housing: individually in polycarbonate cages (48 cm x 27 cm x20 cm)
- Diet : free access to "106 pelleted diet" (UAR, 91360 Villemoisson-sur-Orge, France)
- Water : drinking water filtered by a FG Millipore membrane (0.22 µm), ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/-2°C
- Humidity (%): 30 to 70 %
- Air changes (per hr): approximately 12 cycles/hours of filtered, non-recylcled air
- Photoperiod : 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 1999-04-01 To: 1999-05-03 - Route:
- intradermal and epicutaneous
- Vehicle:
- corn oil
- Concentration / amount:
- Induction (treated group)
- Intradermal injections: Esterol C at the concentration of 75% (W/W) in corn oil
- Topical aplication: Esterol C undiluted
Challenge (all group)
- topical application: Esterol C undiluted - Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- Induction (treated group)
- Intradermal injections: Esterol C at the concentration of 75% (W/W) in corn oil
- Topical aplication: Esterol C undiluted
Challenge (all group)
- topical application: Esterol C undiluted - No. of animals per dose:
- control group (5 males and 5 females)
Treated group (10 males and 10 females) - Details on study design:
- RANGE FINDING TESTS: In a preliminary study, the following concentrations were tested: 75 %, 50 % and 25 %. In order to respect the criteria for the
selection of concentrations (the concentration should be well-tolerated systematically and locally, intradermal injections should cause moderate
irritant effect but no necrosis or ulceration of the skin), concentration chosen for the main study was 75 % (W/W).
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and cutaneous)
- Test groups: Esterol C in Freund's complete adjuvant (FCA) or in corn oil
- Control group: FCA and corn oil
- Site: dorsal skin of the scapular region
- Frequency of applications: on day 1 and day 8
- Duration: 0-8 days
- Concentrations: 75 % (intradermal), undiluted (cutaneous)
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: day 22
- Exposure period: 24h
- Test groups: Esterol C
- Control group: Esterol C
- Site: posterior right flank (test substance), posterior left flank (vehicle)
- Concentrations: O.5 ml (undiluted test substance or vehicle)
- Evaluation (hr after challenge) : 24 and 48
OTHER: - Positive control substance(s):
- yes
- Remarks:
- DNCB (CIT study No. 17335 TSG)-september 1998
- Positive control results:
- The species and strain which were used showed previously a satifactory sensitization response in 90 % animals treated with a positive sensitizer,
2,4 -Dinitro chlorobenzene. (CIT study No. 17335 TSG-September 1998) - Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.5 ml (undiluted test substance)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No clinical signs were observed during the study
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.5 ml (undiluted test substance). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No clinical signs were observed during the study.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.5 ml (undiluted test substance)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No clinical signs were observed during the study
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.5 ml (undiluted test substance). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No clinical signs were observed during the study.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: control group
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No clinical signs were observed during the study
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: control group. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No clinical signs were observed during the study.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: control group
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No clinical signs were observed during the study
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: control group. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No clinical signs were observed during the study.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- The test substance Esterol C does not induce delayed contact hypersensitivity in guinea-pigs.
- Executive summary:
In a dermal sensitization study (Manciaux, 1999) with Esterol C (batch No. 99.06.501) in corn oil, Hartley guinea-pigs were tested using the method of Guinea pig maximisation test. No clinical signs and no deaths were noted during the study. No cutaneous reactions were observed after the challenge application. Under the experimental conditions of the study, Esterol C does not induce delayed contact hypersensitivity in guinea pig.
Reference
The LLNA test has not been performed because a valid Guinea Pig maximisation test is existing
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Not sensitizing
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
There is no human or animal evidence on this endpoint therefore no classification is warranted under 67/548/EEC or Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.